Keros Therapeutics Inc (KROS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $202.13M
Last updated: Nov 17, 2026 at 11:05 AM ET
Keros Therapeutics Inc (KROS) Competitors
The companies most similar to Keros Therapeutics are Protara Therapeutics (TARA), Rocket Pharmaceuticals (RCKT) and Kyverna Therapeutics, Inc. Common Stock (KYTX). By market cap, Keros Therapeutics ranks 8th of the 13 companies on this page; Kyverna Therapeutics, Inc. Common Stock (KYTX) is the largest at $319.27M.
Peer Comparison
KROS's revenue growth of 180.5% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Keros Therapeutics (KROS) | $202.13M | N/A | 4.9x | -151.4% | N/A | 180.5% | 0.00% |
| Protara Therapeutics Inc (TARA) | $155.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Rocket Pharmaceuticals Inc (RCKT) | $256.82M | N/A | N/A | 0.0% | -2.3% | 0.0% | 0.00% |
| Kyverna Therapeutics, Inc. Common Stock (KYTX) | $319.27M | N/A | N/A | 0.0% | -81.5% | 0.0% | 0.00% |
| Korro Bio, Inc. (KRRO) | $186.81M | N/A | 175.8x | 0.0% | -82.8% | -43.1% | 0.00% |
| Bicycle Therapeutics Ltd (BCYC) | $236.22M | N/A | 2.7x | -169.8% | N/A | 190.2% | 0.00% |
| Pyxis Oncology Inc (PYXS) | $188.98M | N/A | 11.6x | 0.0% | N/A | 0.0% | 0.00% |
| Arcturus Therapeutics Holdings Inc (ARCT) | $240.96M | N/A | 7.7x | -285.9% | N/A | 6.7% | 0.00% |
| Immuneering Corp (IMRX) | $240.27M | N/A | N/A | 0.0% | N/A | -99.8% | 0.00% |
| Compass Therapeutics Inc. (CMPX) | $139.35M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Invivyd Inc. (IVVD) | $171.58M | N/A | 2.9x | -183.9% | N/A | 21.2% | 0.00% |
| Prelude Therapeutics Inc (PRLD) | $275.32M | N/A | 16.3x | -269.7% | N/A | 41.0% | 0.00% |
| Lineage Cell Therapeutics Inc (LCTX) | $231.35M | N/A | 18.7x | 16.2% | -6.7% | -61.0% | 0.00% |
| Peer median | $233.78M | N/A | 11.6x | 0.0% | -44.1% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Keros Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Protara Therapeutics Inc (TARA) | Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to identifying and promoting transformative therapies for the treatment... | TARA competitors |
| Rocket Pharmaceuticals Inc (RCKT) | Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. | RCKT competitors |
| Kyverna Therapeutics, Inc. Common Stock (KYTX) | Kyverna Therapeutics, Inc. is an innovative biotechnology company focused on advancing immunotherapies for autoimmune diseases and other significant health... | KYTX competitors |
| Korro Bio, Inc. (KRRO) | Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare... | KRRO competitors |
| Bicycle Therapeutics Ltd (BCYC) | Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments. | BCYC competitors |
| Pyxis Oncology Inc (PYXS) | Pyxis Oncology, Inc., a preclinical biotechnology company, is dedicated to developing antibody-drug conjugate (ADC) and monoclonal antibody (mAb)... | PYXS competitors |
| Arcturus Therapeutics Holdings Inc (ARCT) | Arcturus Therapeutics Holdings Inc., an RNA drug company, focuses on the treatment of liver and respiratory diseases. | ARCT competitors |
| Immuneering Corp (IMRX) | Immuneering Corp (IMRX) is a cutting-edge biotechnology firm dedicated to advancing targeted therapeutics for cancer and other critical illnesses through its... | IMRX competitors |
| Compass Therapeutics Inc. (CMPX) | Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple... | CMPX competitors |
| Invivyd Inc. (IVVD) | Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery... | IVVD competitors |
| Prelude Therapeutics Inc (PRLD) | Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized... | PRLD competitors |
| Lineage Cell Therapeutics Inc (LCTX) | Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapeutics for the treatment... | LCTX competitors |
Frequently Asked Questions About KROS
Who are Keros Therapeutics' main competitors?
The companies most similar to Keros Therapeutics include Protara Therapeutics (TARA), Rocket Pharmaceuticals (RCKT), Kyverna Therapeutics, Inc. Common Stock (KYTX), Korro Bio (KRRO) and Bicycle Therapeutics (BCYC), listed from the closest match.
Who is Keros Therapeutics' biggest competitor?
Kyverna Therapeutics, Inc. Common Stock (KYTX) is the largest of the similar companies at $319.27M; Protara Therapeutics (TARA) is the closest match by business profile, size, sector and industry.
How does KROS stock compare with its competitors?
KROS' P/S is 4.9x against a peer median of 11.6x; its net margin is -151.4% against a peer median of 0.0%.
Which of Keros Therapeutics' competitors pays a higher dividend?
Keros Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Keros Therapeutics bigger than its competitors?
No. Keros Therapeutics is 8th by market cap among the 13 companies on this page; the largest is Kyverna Therapeutics, Inc. Common Stock (KYTX) at $319.27M.
KROS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors